Total Funding
66
51
Total FundingVenture - Series Unknown raised
Growth Score
-8 pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
54469
Starton Therapeutics is a biotechnology company that focuses on transforming standard of care in therapeutics.
- Past Role: Asterias Biotherapeutics, President and CEO
- Rod Hartwig: Vice President of Research, Development, and ManufacturingPast Role: Starton Therapeutics, Executive Director of Product Development
About the Company
Starton Therapeutics is a biotechnology company that focuses on transforming the standard of care in therapeutics. The company develops a transdermal patch technology created to transform chemotherapy-induced nausea and vomiting. It uses proven transdermal technology with proprietary drivers to obtain new indications or develop on-label superiority
for patients with hematological malignancies.
